ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
22
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,241
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Neuropsychiatric adverse effects on dolutegravir: an emerging concern in Europe.
Author(s):
Amélie Menard
1
,
Clementine Montagnac
,
Caroline Solas
,
Line Meddeb
,
Catherine Dhiver
,
Christelle Tomei
,
Isabelle Ravaux
,
Herve Tissot-Dupont
,
Saadia Mokhtari
,
Philippe Colson
,
Andreas Stein
Publication date
(Electronic):
May 15 2017
Journal:
AIDS (London, England)
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Special feature: Europe and Education
Author and article information
Journal
Journal ID (iso-abbrev):
AIDS
Title:
AIDS (London, England)
Publisher:
Ovid Technologies (Wolters Kluwer Health)
ISSN (Electronic):
1473-5571
ISSN (Print):
0269-9370
Publication date (Electronic):
May 15 2017
Volume
: 31
Issue
: 8
Affiliations
[
1
]
aURMITE, UM63, CNRS 7278, IRD 198, IHU-Méditerranée Infection bLaboratoire de Pharmacocinétique et Toxicologie, INSERM UMR 911-CRO2-SMARTc, AP-HM Timone, Aix-Marseille University, Marseille, France.
Article
Publisher Item ID:
00002030-201705150-00020
DOI:
10.1097/QAD.0000000000001459
PubMed ID:
28441180
SO-VID:
4800c597-beb7-441d-8271-5f8b94a541b4
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
3,241
HIV-RNA decay in paired blood and semen samples of subjects receiving their first dolutegravir-based ART regimen
Authors:
Claudia Fabrizio
,
Nicolò de Gennaro
,
Anna Volpe
…
Switch to dolutegravir-based regimens and decrease in sCD14 levels in HIV-1 infected patients on suppressive ART [P84].
Authors:
S Belmonti
,
F. LOMBARDI
,
A Cingolani
Pharmacokinetics, Safety, Tolerability and Antiviral Activity of Dolutegravir Dispersible Tablets in Infants and Children with HIV-1: Results of the IMPAACT P1093 Study, a Phase I/II Open-Label Trial
Authors:
Theodore Dumont Ruel
,
Edward P. Acosta
,
Jessica P. Liu
…
See all similar
Cited by
22
Neuropsychiatric outcomes before and after switching to dolutegravir-based therapy in an acute HIV cohort
Authors:
Phillip Chan
,
Orlanda Goh
,
Eugene Kroon
…
Update on Adverse Effects of HIV Integrase Inhibitors
Authors:
Agnieszka Kolakowska
,
Anaenza Maresca
,
Intira Jeannie Collins
…
Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort
Authors:
Annalisa Mondi
,
Alessandro Cozzi-Lepri
,
Alessandro Tavelli
…
See all cited by